Cargando…

Novel somatic mutations in UBA1 as a cause of VEXAS syndrome

Poulter and colleagues describe a series from the United Kingdom of 10 male patients with VEXAS syndrome, including 2 with novel genetic changes affecting methionine 41 of E1.

Detalles Bibliográficos
Autores principales:	Poulter, James A., Collins, Jason C., Cargo, Catherine, De Tute, Ruth M., Evans, Paul, Ospina Cardona, Daniela, Bowen, David T., Cunnington, Joanna R., Baguley, Elaine, Quinn, Mark, Green, Michael, McGonagle, Dennis, Beck, David B., Werner, Achim, Savic, Sinisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Hematology 2021
Materias:	Letter to Blood
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8462400/ https://www.ncbi.nlm.nih.gov/pubmed/33690815 http://dx.doi.org/10.1182/blood.2020010286

Ejemplares similares

VEXAS syndrome
por: Grayson, Peter C., et al.
Publicado: (2021)

The First Korean Case of VEXAS Syndrome Caused by a UBA1 Somatic Variant
por: Yoon, Jihoon G., et al.
Publicado: (2023)

Early activation of inflammatory pathways in UBA1-mutated hematopoietic stem and progenitor cells in VEXAS
por: Wu, Zhijie, et al.
Publicado: (2023)

Recovery of Bone Marrow Function in VEXAS Syndrome-potential Role for Romiplostim
por: Al-Hakim, Adam, et al.
Publicado: (2023)

Recurrent Mutations of the Active Adenylation Domain of UBA1 in Atypical Form of VEXAS Syndrome
por: Faurel, Alyx, et al.
Publicado: (2023)

Exome sequencing can misread high variant allele fraction of somatic variants in UBA1 as hemizygous in VEXAS syndrome: a case report
por: Wilke, Matheus V. M. B., et al.
Publicado: (2022)

Dominance of an UBA1 mutant clone over a CALR mutant clone: from essential thrombocytemia to VEXAS
por: Hage-Sleiman, Mehdi, et al.
Publicado: (2021)

Spanish cohort of VEXAS syndrome: clinical manifestations, outcome of treatments and novel evidences about UBA1 mosaicism
por: Mascaro, Jose Manuel, et al.
Publicado: (2023)

Somatic Mutations and the Risk of Undifferentiated Autoinflammatory Disease in MDS: An Under-Recognized but Prognostically Important Complication
por: Watad, Abdulla, et al.
Publicado: (2021)

P778: A CARTOGRAPHY OF UBA1 GENE TESTING, EPIDEMIOLOGY AND CLINICAL-GENOMIC CHARACTERISTICS: THE VEXAS ITALIAN EXPERIENCE
por: Gurnari, Carmelo, et al.
Publicado: (2023)

UBA1 Screening in Sweet Syndrome With Hematological Neoplasms Reveals a Novel Association Between VEXAS and Chronic Myelomonocytic Leukemia
por: Gurnari, Carmelo, et al.
Publicado: (2022)

Novel causative variants of VEXAS in UBA1 detected through whole genome transcriptome sequencing in a large cohort of hematological malignancies
por: Sakuma, Maki, et al.
Publicado: (2023)

Somatic TP53 mutations are preleukemic events in acute lymphoblastic leukemia
por: Chitadze, Guranda, et al.
Publicado: (2023)

VEXAS-Syndrom
por: Zeeck, M., et al.
Publicado: (2022)

Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome—clinical presentation of a newly described somatic, autoinflammatory syndrome
por: Alhomida, Faris, et al.
Publicado: (2021)

VEXAS syndrome in a female patient with constitutional 45,X (Turner syndrome)
por: Stubbins, Ryan J., et al.
Publicado: (2021)

Thrombosis in VEXAS syndrome
por: Oo, Thet Mon, et al.
Publicado: (2021)

VEXAS Syndrome—Review
por: Zhang, Yue, et al.
Publicado: (2023)

Human Cord Blood‐Derived Unrestricted Somatic Stem Cell Infusion Improves Neurobehavioral Outcome in a Rabbit Model of Intraventricular Hemorrhage
por: Vinukonda, Govindaiah, et al.
Publicado: (2019)

Azacytidine Treatment for VEXAS Syndrome
por: Raaijmakers, Marc H. G. P., et al.
Publicado: (2021)

VEXAS syndrome with cutaneous nodules
por: Argobi, Yahya
Publicado: (2021)

Communicating the move to individualized donor selection policy: Framing messages focused on recipients and safety
por: Ferguson, Eamonn, et al.
Publicado: (2022)

A clinical, histopathological, and molecular study of two cases of VEXAS syndrome without a definitive myeloid neoplasm
por: Li, Peng, et al.
Publicado: (2022)

Prebiotic galactooligosaccharides interact with mouse gut microbiota to attenuate acute graft-versus-host disease
por: Holmes, Zachary C., et al.
Publicado: (2022)

VEXAS syndrome: a diagnostic puzzle
por: Ruffer, Nikolas, et al.
Publicado: (2023)

Mixed results with baricitinib in biological-resistant adult-onset Still’s disease and undifferentiated systemic autoinflammatory disease
por: Kacar, Mark, et al.
Publicado: (2020)

Shared and Distinct Mechanisms of UBA1 Inactivation Across Different Diseases
por: Collins, Jason C., et al.
Publicado: (2023)

Prediction paradigm involving time series applied to total blood issues data from England
por: Nandi, Anita K., et al.
Publicado: (2020)

Innovations in genomics for undiagnosed diseases: vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome
por: Stubbins, Ryan J., et al.
Publicado: (2022)

Autoimmune-autoinflammatory rheumatoid arthritis overlaps: a rare but potentially important subgroup of diseases
por: Savic, Sinisa, et al.
Publicado: (2017)

Overexpression of UBA5 in Cells Mimics the Phenotype of Cells Lacking UBA5
por: Kumari, Sujata, et al.
Publicado: (2022)

VEXAS syndrome in myelodysplastic syndrome with autoimmune disorder
por: Huang, Huijun, et al.
Publicado: (2021)

VEXAS Syndrome: A Novelty in MDS Landscape
por: Templé, Marie, et al.
Publicado: (2022)

VEXAS Syndrome in a Patient with Myeloproliferative Neoplasia
por: Austestad, Janne, et al.
Publicado: (2023)

Intrapatient competition of VEXAS syndrome and CML clones
por: Djerbi, Nadia, et al.
Publicado: (2023)

HIV incidence and related risks among gay, bisexual, and other men who have sex with men in Montreal, Toronto, and Vancouver: Informing blood donor selection criteria in Canada
por: Lambert, Gilles, et al.
Publicado: (2022)

Pulmonary manifestations in VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome: a systematic review
por: Kouranloo, Koushan, et al.
Publicado: (2023)

Mitigating the risk of transfusion‐transmitted infections with vector‐borne agents solely by means of pathogen reduction
por: Stramer, Susan L., et al.
Publicado: (2022)

Anakinra as a diagnostic challenge and treatment option for systemic autoinflammatory disorders of undefined genetic cause
por: Harrison, S, et al.
Publicado: (2015)

Vexas: A new syndrome not always associated with hemopathy
por: Thomas, Benoît, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_se3u6mi0978m143mvfmq6ln8hl